心力衰竭远程监测:疫情背景下的现状与新兴技术
本文综述了心力衰竭患者远程监测技术的现有证据,指出远程监测可早期提示心衰失代偿并可能优化治疗以预防住院。COVID-19 疫情推动虚拟诊疗快速扩展,作者强调理解远程监测技术与远程医疗服务在 HF 管理中的作用至关重要。
要点
- 远程监测技术可提供心衰失代偿的早期迹象。
- 远程监测可能通过优化治疗预防心衰住院。
- 疫情下虚拟诊疗扩展,需理解远程监测与远程医疗的作用。
核心结论
- 远程监测技术可能为心衰患者提供失代偿早期提示并优化治疗以预防住院。
- 疫情推动虚拟诊疗扩展,需理解远程监测与远程医疗服务在心衰管理中的角色。
研究设计与样本
- 本文为综述,总结心衰患者当前远程监测技术的证据并讨论疫情背景下的应用。
主要发现
- 心衰发病率仍高,心衰患者面临频繁住院风险。
- 远程监测技术可能提供心衰失代偿的早期指征并潜在优化治疗以预防住院。
- COVID-19 疫情导致虚拟诊疗这一新医疗服务模式快速扩展。
临床怎么用
- 在疫情背景下应理解远程监测技术与可靠远程医疗服务在心衰管理中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The incidence of heart failure (HF) remains high and patients with HF are at risk for frequent hospitalisations. Remote monitoring technologies may provide early indications of HF decompensation and potentially allow for optimisation of therapy to prevent HF hospitalisations. The need for reliable remote monitoring technology has never been greater as the COVID-19 pandemic has led to the rapid expansion of a new mode of healthcare delivery: the virtual visit. With the convergence of remote monitoring technologies and reliable method of remote healthcare delivery, an understanding of the role of both in the management of patients with HF is critical. In this review, we outline the evidence on current remote monitoring technologies in patients with HF and highlight how these advances may benefit patients in the context of the current pandemic.
引用
- Mohebali D, Kittleson MM. Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic. Heart. 2021. PMID: 33431425. doi:10.1136/heartjnl-2020-318062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。